Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Al-Sebai, M.A.H.
Right arrow Articles by Hipkin, L.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Sebai, M.A.H.
Right arrow Articles by Hipkin, L.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 11, No. 4, pp. 881-888, 1996
© 1996 European Society of Human Reproduction and Embryology


research-article

The role of a single free {beta}-human chorionic gonadotrophin measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability

M.A.H. Al-Sebai1, M. Diver2 and L.J. Hipkin2,3

1Department of Obstetrics and Gynaecology, Royal Liverpool University Hospital Prescot Street, Liverpool L7 8XP 2Endocrine Laboratory, University Department of Clinical Chemistry, Alder Hey Hospital Eaton Road, Liverpool L12 2AP, UK

Correspondence: 3To whom correspondence should be addressed at: The University Department of Clinical Chemistry, Duncan Building, Royal Liverpool University Hospital, Prescot Street, PO Box 147, Liverpool L69 3BX, UK

This prospective controlled study investigated the concentrations of free {beta}-human chorionic gonadotrophin (HCG) subunit in 554 women with a singleton intrauterine or tubal pregnancy. They presented with vaginal bleeding and/or abdominal pain in the first 18 weeks of pregnancy. The control group comprised 156 women with musculo-skeletal pain and no vaginal bleeding. Their pregnancies continued to term. The study group comprised 398 women (141 threatened-continuing pregnancies, 37 threatened-miscarriages, 185 non-continuing pregnancies and 35 tubal pregnancies). Free {beta}-HCG concentrations were significantly lower in the non-continuing, threatened-miscarriage and tubal pregnancy groups [mean 4.62, 6.50 and 4.27 ng/ml respectively; 95% confidence interval (CI) 3.75–-5.69, 4.46–9.48 and 2.92–6.2 respectively] than in the control and threatened-continuing groups (mean 41.61 and 48.22 ng/ml respectively; 95% CI 34.53–50.13 and 42.03–55.32 respectively) (P < 0.001 in all cases). A cut-off value at 20 ng/ml was found to differentiate between the ‘viable’ (control and threatened-continuing) and the ‘abnormal’ (non-continuing, threatened-miscarriage and tubal) pregnancies, with 88.3% sensitivity and 82.6% positive predictive value. An excellent diagnostic and prognostic usability of free {beta}HCG was confirmed by a receiver operating characteristic curve plot In conclusion, a single serum free {beta}-HCG measurement taken in early pregnancy is valuable in the immediate diagnosis of early pregnancy failure and the long-term prognosis of viability.

Key words: early pregnancy failure/fetal viability/free {beta}-HCG/normal early pregnancy/tubal pregnancy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
A. Yin, E.H.Y. Ng, X. Zhang, Y. He, J. Wu, and K.Y. Leung
Correlation of maternal plasma total cell-free DNA and fetal DNA levels with short term outcome of first-trimester vaginal bleeding
Hum. Reprod., June 1, 2007; 22(6): 1736 - 1743.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A. Sotiriadis, S. Papatheodorou, and G. Makrydimas
Threatened miscarriage: evaluation and management
BMJ, July 17, 2004; 329(7458): 152 - 155.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
P. von Lode, J. Rainaho, and K. Pettersson
Quantitative, Wide-Range, 5-Minute Point-of-Care Immunoassay for Total Human Chorionic Gonadotropin in Whole Blood
Clin. Chem., June 1, 2004; 50(6): 1026 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.E. Sugantha, S. Webster, E. Sundar, and E.A. Lenton
Predictive value of plasma human chorionic gonadotrophin following assisted conception treatment
Hum. Reprod., February 1, 2000; 15(2): 469 - 473.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.